483
Dendreon Pharmaceuticals LLCFDA 483 - Dendreon Pharmaceuticals LLC - November 08, 2019
Record Details
An FDA inspection of Dendreon Pharmaceuticals, LLC in Seal Beach, CA, a biologic drug manufacturer, revealed significant deficiencies across multiple areas. The firm was cited for issues including inadequate batch production records, untimely investigations into sterility failures, and a lack of proper procedures for aseptic processing and environmental monitoring. Additional concerns involved insufficient data verification, improper material handling and storage, and inadequate temperature control and equipment maintenance.
Open in Dashboard
ID · 00e3c702-5196-4c88-8791-bb84ac9d5006